Maravai Lifesciences Holdings Cash Flow Statement (2020-2026) | MRVI

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
132.18M127.11M146.86M156.72M99.65M87.43M-1.35M-11.94M-15.10M-109.98M-22.68M-18.42M-172.46M-46.07M-52.85M-69.84M-45.06M-63.02M-6.38M-21.63M
Depreciation and Depletion (Quarter)
1.80M1.75M1.85M1.89M1.86M2.00M2.08M2.81M4.07M3.93M4.79M5.56M5.04M5.51M5.69M5.96M5.97M5.97M4.90M5.31M
Share-based Compensation (Quarter)
8.23M2.23M0.77M7.10M9.64M5.99M12.06M13.76M13.05M-37.58M10.40M-9.94M29.71M6.74M10.21M
Deferred Taxes (Quarter)
11.23M17.47M13.22M12.86M9.23M7.01M-1.52M-2.76M-5.53M764.75M0.01M
Gains from Investment Securities (Quarter)
-7.80M-7.80M-5.29M-2.32M2.38M-3.35M-1.20M-0.18M-0.63M0.14M
Asset Writedowns and Impairment (Quarter)
12.44M4.90M0.60M-0.14M
Cash from Operations (Quarter)
105.56M58.74M162.30M164.28M110.06M99.33M85.07M19.19M14.17M7.79M-8.47M17.43M13.14M-14.64M-9.39M-10.27M-15.15M-22.77M8.66M3.99M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
154.24M166.20M30.40M
Amortization of Deferred Charges (Quarter)
0.68M0.68M0.70M1.94M-0.51M0.65M0.72M3.47M-2.01M0.74M0.74M3.48M2.10M2.16M2.19M2.23M2.26M-5.02M1.61M1.62M
Depreciation & Amortization (CF) (Quarter)
1.80M1.75M1.85M1.89M1.86M2.00M2.08M2.81M4.07M3.93M4.79M5.56M5.04M5.51M5.69M5.96M5.97M5.97M4.90M5.31M
Change in Working Capital
Change in Receivables (Quarter)
-17.62M51.54M2.22M0.12M-5.83M25.77M-82.41M-7.56M-3.21M8.79M-17.88M-1.89M-6.02M11.43M-10.16M-0.50M-5.12M2.96M7.91M-2.29M
Change in Inventory (Quarter)
8.56M-5.48M-1.20M8.70M2.31M-19.27M3.38M-7.71M1.50M2.18M-0.82M-0.70M1.60M-0.45M-0.45M-3.11M-1.35M-3.09M-0.03M0.77M
Change in Account Payables (Quarter)
-2.62M-0.87M1.95M4.36M-4.42M-3.47M-0.23M1.87M1.99M1.66M-3.68M4.57M-2.42M2.25M-0.71M1.78M-2.91M-5.51M6.16M-1.80M
Change in Accured Expenses (Quarter)
1.62M7.47M-4.06M2.29M15.89M-5.61M24.23M-17.64M2.38M6.40M-24.12M3.00M-1.06M-1.56M1.84M5.54M1.51M-13.51M-5.34M1.81M
Other Working Capital Changes (Quarter)
0.97M3.48M-2.52M12.57M26.32M-0.47M23.01M-21.29M-3.48M0.90M-0.73M0.20M-0.44M0.82M-2.24M2.86M-1.07M0.26M-1.43M0.77M
Investing Activities
Capital Expenditures (Quarter)
8.16M-7.04M1.74M2.67M6.47M-9.18M7.87M25.06M15.83M-46.74M3.16M12.06M8.59M-21.19M1.43M6.67M-7.19M12.23M4.44M0.37M
Sales of Property, Plant and Equipment (Quarter)
Acquisitions (Quarter)
238.84M0.13M69.73M-0.11M18.63M0.36M
Divestments (Quarter)
120.70M
Cash from Investing Activities (Quarter)
118.63M-5.66M-241.58M-1.66M-5.85M-18.52M-69.73M-24.16M-15.52M-12.90M-4.24M-6.18M-8.96M-4.93M-23.13M-3.24M-2.93M-2.11M-4.44M-0.37M
Financing Activities
Other financing activities (Quarter)
0.31M-1.33M1.26M0.73M-1.99M0.49M1.40M1.96M-4.20M2.38M2.34M2.35M2.23M-3.54M4.92M-3.87M3.41M
Cash from Financing Activities (Quarter)
-51.28M-49.58M-40.52M-43.41M-37.44M-66.12M-19.21M-43.13M0.78M0.47M-0.56M0.23M0.81M-236.19M-4.90M-1.53M-8.25M-1.82M-55.23M-98.98M
Dividend Payments
Dividends Paid - Common (Quarter)
50.09M110.00M39.89M42.59M36.81M30.92M8.30M1.30M0.57M-0.08M
Additional items
Exchange Rate Effect (Quarter)
0.03M-0.13M0.07M-0.11M-0.01M0.01M0.03M0.02M
Change in Cash (Quarter)
173.19M3.37M-119.80M119.21M66.77M14.69M-3.87M-48.10M-0.57M-4.64M-13.27M11.48M4.99M-255.76M-37.35M-15.15M-26.33M-26.68M-50.97M-95.34M
Free Cash Flow (Quarter)
97.40M65.79M160.56M161.61M103.59M108.51M77.21M-5.87M-1.66M54.53M-11.63M5.38M4.54M6.55M-10.82M-16.94M-7.96M-35.00M4.23M3.62M
Net Cash Flow (Quarter)
172.91M3.51M-119.80M119.21M66.77M14.69M-3.87M-48.10M-0.57M-4.64M-13.27M11.48M4.99M-255.76M-37.42M-15.04M-26.32M-26.70M-51.00M-95.36M